Sign in to view content

GATHER2 Phase 3 Efficacy Results and GATHER2 Phase 3 Safety Results

Jeffrey S. Heier, MD
Arshad M. Khanani, MD, MA, FASRS

Video
Published 2022

Related

Pegcetacoplan Safety: Panel Recap
Andre J. Witkin, MD
Updates from the Field
2024
Geographic Atrophy in the Canadian Treat and Extend Trial With Ranibizumab in nAMD Patients: CANTREAT Study 24-Month Results
Peter J. Kertes, MD, FRCS(C)
Annual Meeting Talks
2019
Episode 15: Serum VEGF Levels in the IVAN Trial with Dr. Usha Chakravarthy
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018

Category: AMD-Non-Neovascular

See more